Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors. - Wikidata - wikimedia - TriplyDB

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

http://www.wikidata.org/entity/Q39198277

about

Mesenchymal stem cells as delivery vectors for anti-tumor therapy Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells.Neural stem cell therapy for cancer.Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors.Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells.PTEN-mRNA engineered mesenchymal stem cell-mediated cytotoxic effects on U251 glioma cells TRAIL on trial: preclinical advances in cancer therapy E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice.Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors.Stem cell-based therapies for cancer treatment: separating hope from hype.Engineering Stem Cells for Biomedical Applications.Drug delivery approaches for the treatment of glioblastoma multiforme.Use of genetically engineered stem cells for glioma therapy.Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.Stem cell-based therapies for tumors in the brain: are we there yet?Harnessing mesenchymal stem cell homing as an anticancer therapy.Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level.Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors.PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance.A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression Viral gene therapy for breast cancer: progress and challenges.Mesenchymal stem cells: A new platform for targeting suicide genes in cancer.Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype.Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial.Stem cells in cancer therapy: opportunities and challenges.Optimized Longitudinal Monitoring of Stem Cell Grafts in Mouse Brain Using a Novel Bioluminescent/Near Infrared Fluorescent Fusion Reporter.The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor.Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.Mutual Destruction of Deep Lung Tumor Tissues by Nanodrug-Conjugated Stealth Mesenchymal Stem Cells.Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms.Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms Concise Review: Mesenchymal Stem Cell-Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise

P2860

Q26861201-415A0CDC-25C5-4057-B770-69574FA322F2 Q27002209-E3D7C018-0A52-4EDB-A4A9-2B62A2B9E9B0 Q30854013-B5CCD8AC-3B60-4AB8-8CEB-F9E77A08D99F Q33704489-FA0A3FAD-0E28-42FC-87C3-0600B81FB91B Q35153149-5E4411FA-C969-4515-B307-1EA275CA0ED2 Q35553117-6EC8C3CD-0EB0-4CDC-8AFC-BB5B0616C463 Q35974503-36204EB9-BEF4-4DE1-AEE7-5830308DAC69 Q36742113-02C998E5-C14F-4FC5-BDFE-154CBCE3A8E6 Q37433463-B28B34D9-B896-4770-B853-94A078CC85A6 Q37588372-3EFECE3F-2FF5-4EC1-B1D5-4C765333895C Q38139850-4D6AE568-D6D7-427F-9D6C-813FAB92248B Q38245163-5E3C9074-DCA9-4ACA-A8E2-AC880E021860 Q38378499-9733F2FE-B7FE-4DCF-80C4-0D58577A0671 Q38517047-86064176-97B7-4698-956C-B60EA7622BA5 Q38730790-FB3E583B-5A8D-4F39-9327-0B05C09ED629 Q38803932-0784D65E-3D94-4267-9115-745BC59FDC35 Q38855638-DAE807E3-EBD6-4A83-8393-5085E264B764 Q38857484-55CEA08F-554A-4DFF-B35D-26DDC478F6F2 Q38919180-8D0EE1EF-344D-4639-AA4F-B675D52A3479 Q38944271-1CE12F74-E8A9-482C-AED6-CF258F3A399B Q38960128-9E937C28-9E53-4EBB-A693-5FB85A38E09A Q38974708-2B688761-23D5-49BE-B1D4-504DC021F1E0 Q39030703-6617468D-9D1D-488E-A5D2-D68D314D5559 Q39366114-B2DB3EBD-F2FA-4462-BBDD-6A9EE24A115D Q39432344-E299A0A8-FEA0-41E9-B668-FDE64A2C08B7 Q42218017-6B37FDE2-F1AE-4CCA-A6EC-F0E9A1DC0AF2 Q42391294-A84AB2E9-705B-48F3-82AE-2C9AF1775475 Q42654111-6904269A-3A7C-42BB-9BF6-951F82D39E52 Q43063875-C2833EE3-D691-4B64-B945-59FBDF6DB1F5 Q47142453-5C1BCE54-E803-4B65-8830-D62FC7C1E7AF Q47825737-E979D9CB-DCD5-495C-88C8-DFF21618B04E Q49804881-A0398A92-8272-4557-A336-1AD2D302DA99 Q52608756-61582863-A95F-450B-979F-58C0723FDD10 Q55155227-727DD84A-A7FD-4925-A016-0A271B3709A9 Q55379548-5557B44A-0631-49B0-B014-12B96F036143 Q55379731-072B9FB0-8ACB-4B54-99A4-3615C86C3AE7 Q58554616-A4B6211B-DC1D-447A-90BD-10E2707711DC Q58804653-0D2DCAF7-9E38-45BB-8F47-FE503B27DCD4

P2860

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

http://www.wikidata.org/entity/Q39198277

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

@en

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

@nl

type

label

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

@en

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

@nl

prefLabel

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

@en

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

@nl

P1433

Q39198277-B7F4D2F9-961B-4A73-B810-7017CC8431AC

P1476

Q39198277-C0AA01B9-3B18-4AB4-9E3E-9B8B4F1FE831

P2093

Q39198277-4C053271-03FC-458A-A892-824472944FB6

Q39198277-8D042B97-9495-45ED-AF9C-C33E0377AE90

Q39198277-9B336D2A-84CF-4206-890B-751556A88018

Q39198277-A08E185A-4B80-4E64-893A-59742D3AE44B

Q39198277-B6A315FD-5A9E-4738-84A7-A9852617F72C

Q39198277-C94B652D-85C4-4A7F-9C1D-8B49DC74444B

P2860

Q39198277-013EC788-D0A3-490F-9E9A-5136D6D36DD4

Q39198277-04AC2E30-FA5F-4583-85E7-348295F6CD00

Q39198277-065CB134-7E9E-46B6-B79C-A37967F04A6B

Q39198277-0932E29B-845C-4A02-9F75-48CBB714F224

Q39198277-0BB33E8F-CF8E-4DE2-8E83-FC6D6CAC2E0D

Q39198277-0E3A9C74-1E22-48CE-B3E9-773891FBAA60

Q39198277-191188F9-E202-46E0-A115-523E353CB87F

Q39198277-1EDE3E48-0CB5-4AAC-9BAC-3662EE9DD3AD

Q39198277-20B03DD2-3F03-43B9-A513-D0340EC6DC73

Q39198277-24A59CC7-9E96-4CD5-86E9-7663711B1FDA

P304

Q39198277-0A35B837-2E28-4E00-9819-8F20CCC0EE7D

P31

Q39198277-BA250EC2-2B92-44BC-BA5C-2794E5878B39

P356

Q39198277-38EAC6A7-1275-4086-9407-5378C46C1E91

P433

Q39198277-120FF249-4BDB-4FD1-BCF4-8168F3931585

P478

Q39198277-9F3943E2-DD5B-4642-BB06-D10C308571EF

P577

Q39198277-603810FB-E35D-4406-86F4-2F470DF7561E

P5875

Q39198277-1870A618-F999-4FAB-81BC-F3EF81C1E194

P698

Q39198277-752ACD53-830B-45E1-B94A-4215005B1EF2

P932

Q39198277-DAE1ABFF-686E-4A99-8A6C-16249F16A50A

P356

P1433

P1476

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.

@en

P2093

Deepak Bhere

http://www.w3.org/2001/XMLSchema#string

Derek He

http://www.w3.org/2001/XMLSchema#string

Jordi Martinez-Quintanilla

http://www.w3.org/2001/XMLSchema#string

Khalid Shah

http://www.w3.org/2001/XMLSchema#string

Pedram Heidari

http://www.w3.org/2001/XMLSchema#string

Umar Mahmood

http://www.w3.org/2001/XMLSchema#string

P2860

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography.

Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.

Imaging modalities for the staging of patients with colorectal cancer.

Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application.

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

P304

1706-1714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.1355

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235416259

http://www.w3.org/2001/XMLSchema#string

P698

23389839

http://www.w3.org/2001/XMLSchema#string

P932

3775922

http://www.w3.org/2001/XMLSchema#string